Show simple item record

dc.contributor.authorWhetton, Anthony D
dc.contributor.authorPreston, G. W.
dc.contributor.authorAbubeker, S.
dc.contributor.authorGeifman, N.
dc.date.accessioned2020-08-17T07:21:38Z
dc.date.available2020-08-17T07:21:38Z
dc.date.issued2020en
dc.identifier.citationWhetton AD, Preston GW, Abubeker S, Geifman N. Proteomics and Informatics for Understanding Phases and Identifying Biomarkers in COVID-19 Disease. J Proteome Res. 2020.en
dc.identifier.pmid32657586en
dc.identifier.doi10.1021/acs.jproteome.0c00326en
dc.identifier.urihttp://hdl.handle.net/10541/623179
dc.description.abstractThe emergence of novel coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 coronavirus, has necessitated the urgent development of new diagnostic and therapeutic strategies. Rapid research and development, on an international scale, has already generated assays for detecting SARS-CoV-2 RNA and host immunoglobulins. However, the complexities of COVID-19 are such that fuller definitions of patient status, trajectory, sequelae, and responses to therapy are now required. There is accumulating evidence-from studies of both COVID-19 and the related disease SARS-that protein biomarkers could help to provide this definition. Proteins associated with blood coagulation (D-dimer), cell damage (lactate dehydrogenase), and the inflammatory response (e.g., C-reactive protein) have already been identified as possible predictors of COVID-19 severity or mortality. Proteomics technologies, with their ability to detect many proteins per analysis, have begun to extend these early findings. To be effective, proteomics strategies must include not only methods for comprehensive data acquisition (e.g., using mass spectrometry) but also informatics approaches via which to derive actionable information from large data sets. Here we review applications of proteomics to COVID-19 and SARS and outline how pipelines involving technologies such as artificial intelligence could be of value for research on these diseases.en
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1021/acs.jproteome.0c00326en
dc.titleProteomics and informatics for understanding phases and identifying biomarkers in COVID-19 diseaseen
dc.typeArticleen
dc.contributor.departmentStoller Biomarker Discovery Centre, Faculty of Biology Medicine and Health (FBMH), University of Manchester, Manchester M20 4GJen
dc.identifier.journalJournal of Proteome Researchen
dc.description.noteen]
refterms.dateFOA2020-08-18T08:28:44Z


Files in this item

Thumbnail
Name:
32657586.pdf
Size:
3.029Mb
Format:
PDF
Description:
From UNPAYWALL

This item appears in the following Collection(s)

Show simple item record